AstraZeneca agrees to buy ZS Pharma for $2.7 billion

November 6, 2015 7:19 AM

90 0

AstraZeneca agrees to buy ZS Pharma for $2.7 billion

LONDONBritain's AstraZeneca Plc (AZN.L) said on Friday it had agreed to buy ZS Pharma (ZSPH.O), paying a total $2.7 billion for its proprietary technology to develop novel treatments for hyperkalaemia, or high potassium levels.

AstraZeneca said it had agreed to pay $90 a share for the San Mateo, California-based firm.

Also read: Australia, India deals boost French arms sales to record 20 billion euros in 2016

Read more

To category page

Loading...